Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Sexually transmitted diseases, also known as a venereal disease, are infections transmitted through sexual contact and are caused by viruses, bacteria, and parasites. Apart from sexual contact, STDs can in some cases also be transmitted through breastfeeding, childbirth as well as with the shared usage of needles. Gonorrhea, HIV, HPV, chlamydia, and syphilis are the common types of STDs. STDs include more than 25-30 infectious that are transmitted through sexual activity. Infections such as Gonorrhea, HIV, HPV, chlamydia, and syphilis are common among infected individuals. STDs are a substantial health challenge facing globally. Antibiotics can cure chlamydia, gonorrhea, and syphilis. Untreated STD’s put men, women, and infants at risk for severe, lifelong health outcomes like chronic pain, severe reproductive health complications, and HIV.
The growth of the global Sexually Transmitted Diseases Testing Market is mainly attributed lack of awareness about sexually transmitted diseases and growing demand for POC testing.
The rise in patient awareness such as education campaigns and growing government initiatives along with public health laboratories providing sound utilities for STD testing, and provision of insurance coverage are driving industry growth over the forecast period. Sexually transmitted disease testing market has been increased by the high number of patients suffering from STDs. Further, rising number of technologically advanced products in the field of diagnostics, providing more precise testing results a significant shift observed from traditional laboratory testing to rapid point of care testing, fuels the growth with a technologically advanced product range including diagnostic kits, instruments, and reagents.
The report analyses the global sexually transmitted diseases testing market based by types, location of testing, devices and geography.
Sexually Transmitted Diseases Testing Market by disease type is bifurcated into Chlamydia testing, Syphilis testing, Gonorrhea testing, Herpes Simplex Virus testing, Human Papilloma Virus testing, Human Immunodeficiency Virus testing, Chancroid testing among others. Chlamydia testing segment is observed to be experience lucrative growth majorly due to rising prevalence chlamydia. Chlamydia trachomatis is the most commonly reported sexually transmitted infection in the world. The rate of reported chlamydia infection diagnoses continues to increase. As per Centers for Disease Control and Prevention data, approximately 1.7 million cases reported in 2017 in the United States. women (ages 15-24) account for nearly half (45 percent) of reported cases and face the most severe consequences. The market expected to exhibit healthy growth in the near future due to the increasing focus on treatment of sexually transmitted diseases globally.
Based on location of testing, the market is segmented into Laboratory Testing and Point of Care (PoC) Testing. The laboratory testing segment comprises of Commercial/Private Labs and Public Health Labs. Point of Care (PoC) Testing segment is observed to anticipate lucrative growth over the forecast period owing the advantages offered by the point of care testing devices. One of the major advantages of POCT is that it provides much faster access to test results, allowing for more rapid clinical decision making and more-appropriate treatments and interventions.
The testing devices used for STD diagnosis are segmented on the basis of laboratory devices and point of care testing devices. The laboratory devices include PCR, Immunochromatographic capillary flow dipstick technology (Assay), Flow Cytometers, Differential Light Scattering Machines, Enzyme Linked Immunosorbent Assay (ELISA) among others. The point of care testing devices segment includes phone chips, microfluidics, immunochromatographic tests (ICTs) and rapid diagnostic kits.
Flow cytometry is a biophysical, laser-based analytical technology that measures and analyzes several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods including its ability to deliver precise and accurate results, and lesser time consumption at about same prices.
Geographically, Sexually Transmitted Diseases Testing Market is studies across North America, Europe, Asia Pacific and Rest of the World.
The global sexually transmitted diseases diagnostics market is dominated by North America owing to the presence of public healthcare insurance plans fostering healthcare coupled with rise in the adoption of technologically advanced products and provision of insurance coverage in this region. Furthermore, the growing awareness about STD testing and the initiatives taken by governments to promote various tests will boost the growth of the STD disease testing market in this region.
Asia Pacific is anticipated to observe a lucrative market growth over the forecast period owing to the factors including rising prevalence of sexually transmitted infections in the underdeveloped countries of Asia Pacific as well as the economic prosperity in these regions supports the growth of sexually transmitted diseases diagnostics. Further, high growth rate is attributed to growing healthcare organizations, growing healthcare initiatives taken up by government, and rising awareness regarding newer technologies is likely to enhance the growth of the market
The major companies operating in sexually transmitted diseases testing market includes Becton Dickinson and company, Roche Holdings AG, Hologic Inc., BioMerieux, Alere Inc., Danaher Corporation, Abbott Laboratories, Affymetrix, DiaSorin, Cepheid Inc. and Orasure among others.
The report analyses the global sexually transmitted diseases testing market based by types, location of testing, devices and geography.
Sexually Transmitted Diseases Testing Market by disease type is bifurcated into Chlamydia testing, Syphilis testing, Gonorrhea testing, Herpes Simplex Virus testing, Human Papilloma Virus testing, Human Immunodeficiency Virus testing, Chancroid testing among others.Based on location of testing, the market is segmented into Laboratory Testing and Point of Care (PoC) Testing. The laboratory testing segment comprises of Commercial/Private Labs and Public Health Labs.
The testing devices used for STD diagnosis are segmented on the basis of laboratory devices and point of care testing devices. The laboratory devices include PCR, Immunochromatographic capillary flow dipstick technology (Assay), Flow Cytometers, Differential Light Scattering Machines, Enzyme Linked Immunosorbent Assay (ELISA) among others. The point of care testing devices segment includes phone chips, microfluidics, immunochromatographic tests (ICTs) and rapid diagnostic kits.
The major companies operating in sexually transmitted diseases testing market includes Becton Dickinson and company, Roche Holdings AG, Hologic Inc., BioMerieux, Alere Inc., Danaher Corporation, Abbott Laboratories, Affymetrix, DiaSorin, Cepheid Inc. and Orasure among others.
Why to buy this report:
